UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Appropriateness of Allogeneic Red Blood Cell Transfusion: The International Consensus Conference on Transfusion Outcomes

Transfusion medicine reviews, 2011-07, Vol.25 (3), p.232-246.e53

2011

Volltextzugriff (PDF)

Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells

Transfusion (Philadelphia, Pa.), 1999-07, Vol.39 (7), p.701-710

1999

Volltextzugriff (PDF)

Hypovitaminosis D in Medical Inpatients

The New England journal of medicine, 1998-03, Vol.338 (12), p.777-783

1998

Volltextzugriff (PDF)

FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG)

British journal of cancer, 2006-03, Vol.94 (6), p.798-805

2006

Volltextzugriff (PDF)

Intravascular versus surface cooling for targeted temperature management after out-of-hospital cardiac arrest - an analysis of the TTM trial data

Critical care (London, England), 2016-11, Vol.20 (1), p.381-10, Article 381

2016

Volltextzugriff (PDF)

A survey of the demographics of blood use

Transfusion medicine (Oxford, England), 2007-02, Vol.17 (1), p.1-15

2007

Volltextzugriff (PDF)

A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trial

British journal of cancer, 2012-12, Vol.107 (12), p.1932-1937

2012

Volltextzugriff (PDF)

Pemetrexed versus erlotinib in pretreated patients with advanced non–small cell lung cancer: A Hellenic Oncology Research Group (HORG) randomized phase 3 study

Cancer, 2013-08, Vol.119 (15), p.2754-2764

2013

Volltextzugriff (PDF)

RBC transfusion and postoperative length of stay in the hospital or the intensive care unit among patients undergoing coronary artery bypass graft surgery: the effects of confounding factors

Transfusion (Philadelphia, Pa.), 2000-07, Vol.40 (7), p.832-839

2000

Volltextzugriff (PDF)

Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC)

British journal of cancer, 2012-01, Vol.106 (3), p.453-459

2012

Volltextzugriff (PDF)

Carcinoma of the Fallopian Tube: A Clinicopathological Study of 105 Cases with Observations on Staging and Prognostic Factors

Gynecologic oncology, 1999-03, Vol.72 (3), p.367-379

1999

Volltextzugriff (PDF)

BRCA1 and BRCA2 germline testing in Cretan isolates reveals novel and strong founder effects

International journal of cancer, 2020-09, Vol.147 (5), p.1334-1342

2020

Volltextzugriff (PDF)

Postoperative complications associated with transfusion of platelets and plasma in cardiac surgery

Transfusion (Philadelphia, Pa.), 2011-12, Vol.51 (12), p.2603-2610

2011

Volltextzugriff (PDF)

A phase II, open-label trial of bortezomib (VELCADE®) in combination with gemcitabine and cisplatin in patients with locally advanced or metastatic non-small cell lung cancer

Cancer chemotherapy and pharmacology, 2016-05, Vol.77 (5), p.949-956

2016

Volltextzugriff (PDF)

Cisplatin in combination with metronomic vinorelbine as front-line treatment in advanced non-small cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)

Cancer chemotherapy and pharmacology, 2015-04, Vol.75 (4), p.821-827

2015

Volltextzugriff (PDF)

Allogeneic blood transfusion and postoperative duration of mechanical ventilation: effects of red cell supernatant, platelet supernatant, plasma components and total transfused fluid

Vox sanguinis, 2002-04, Vol.82 (3), p.141-149

2002

Volltextzugriff (PDF)

RBC alloantibody specificity and antigen potency in Olmsted County, Minnesota

Transfusion (Philadelphia, Pa.), 2001-11, Vol.41 (11), p.1413-1420

2001

Volltextzugriff (PDF)

Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study

BMC cancer, 2007-05, Vol.7 (1), p.91-91, Article 91

2007

Volltextzugriff (PDF)

Human Papillomavirus Frequency in Oral and Oropharyngeal Cancer in Greece

Anticancer research, 2008-07, Vol.28 (4B), p.2077-2080

2008

Volltextzugriff (PDF)

Weekly Paclitaxel and Carboplatin Plus Bevacizumab as First-Line Treatment of Metastatic Triple-Negative Breast Cancer. A Multicenter Phase II Trial by the Hellenic Oncology Research Group

Clinical breast cancer, 2018-02, Vol.18 (1), p.88-94

2018

Volltextzugriff (PDF)

Biweekly carboplatin plus gemcitabine as first-line treatment of elderly patients with advanced squamous non-small-cell lung cancer: A multicenter phase I-II trial by the Hellenic Oncology Research Group

Clinical lung cancer, 2016-11, Vol.17 (6), p.543-549

2016

Volltextzugriff (PDF)

Docetaxel, gemcitabine and bevacizumab as salvage chemotherapy for HER-2-negative metastatic breast cancer

Cancer chemotherapy and pharmacology, 2015-01, Vol.75 (1), p.153-160

2015

Volltextzugriff (PDF)

Allogeneic blood transfusion, hospital charges, and length of hospitalization: a study of 487 consecutive patients undergoing colorectal cancer resection

Archives of pathology & laboratory medicine (1976), 1998-02, Vol.122 (2), p.145

1998

Volltextzugriff (PDF)

Salvage treatment with irinotecan/cisplatin versus pemetrexed/cisplatin in patients with non-small cell lung cancer pre-treated with a non-platinum-based regimen in the first-line setting: a randomized phase II study of the Hellenic Oncology Research Group (HORG)

Clinical & translational oncology, 2017-03, Vol.19 (3), p.317-325

2017

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(95)

Publikationsform

Artikel
(103)

Sprache

Englisch
(103)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Appropriateness of Allogeneic Red Blood Cell Transfusion: The International Consensus Conference on Transfusion Outcomes

Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells

Hypovitaminosis D in Medical Inpatients

FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG)

Intravascular versus surface cooling for targeted temperature management after out-of-hospital cardiac arrest - an analysis of the TTM trial data

A survey of the demographics of blood use

A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trial

Pemetrexed versus erlotinib in pretreated patients with advanced non–small cell lung cancer: A Hellenic Oncology Research Group (HORG) randomized phase 3 study

RBC transfusion and postoperative length of stay in the hospital or the intensive care unit among patients undergoing coronary artery bypass graft surgery: the effects of confounding factors

Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC)

Carcinoma of the Fallopian Tube: A Clinicopathological Study of 105 Cases with Observations on Staging and Prognostic Factors

BRCA1 and BRCA2 germline testing in Cretan isolates reveals novel and strong founder effects

Postoperative complications associated with transfusion of platelets and plasma in cardiac surgery

A phase II, open-label trial of bortezomib (VELCADE®) in combination with gemcitabine and cisplatin in patients with locally advanced or metastatic non-small cell lung cancer

Cisplatin in combination with metronomic vinorelbine as front-line treatment in advanced non-small cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)

Allogeneic blood transfusion and postoperative duration of mechanical ventilation: effects of red cell supernatant, platelet supernatant, plasma components and total transfused fluid

RBC alloantibody specificity and antigen potency in Olmsted County, Minnesota

Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study

Human Papillomavirus Frequency in Oral and Oropharyngeal Cancer in Greece

Weekly Paclitaxel and Carboplatin Plus Bevacizumab as First-Line Treatment of Metastatic Triple-Negative Breast Cancer. A Multicenter Phase II Trial by the Hellenic Oncology Research Group

Biweekly carboplatin plus gemcitabine as first-line treatment of elderly patients with advanced squamous non-small-cell lung cancer: A multicenter phase I-II trial by the Hellenic Oncology Research Group

Docetaxel, gemcitabine and bevacizumab as salvage chemotherapy for HER-2-negative metastatic breast cancer

Allogeneic blood transfusion, hospital charges, and length of hospitalization: a study of 487 consecutive patients undergoing colorectal cancer resection

Salvage treatment with irinotecan/cisplatin versus pemetrexed/cisplatin in patients with non-small cell lung cancer pre-treated with a non-platinum-based regimen in the first-line setting: a randomized phase II study of the Hellenic Oncology Research Group (HORG)

Aktive Filter

Suchergebnisse filtern